RS20090211A - Pyrazole analogs - Google Patents

Pyrazole analogs

Info

Publication number
RS20090211A
RS20090211A RSP-2009/0211A RSP20090211A RS20090211A RS 20090211 A RS20090211 A RS 20090211A RS P20090211 A RSP20090211 A RS P20090211A RS 20090211 A RS20090211 A RS 20090211A
Authority
RS
Serbia
Prior art keywords
compounds
disorders
preparation
conditions
pyrazole analogs
Prior art date
Application number
RSP-2009/0211A
Other languages
English (en)
Inventor
Todd Michael Maddux
Matthew J. Graneto
Jaime L. Masferrer
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of RS20090211A publication Critical patent/RS20090211A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Ovaj pronalazak se odnosi na jedinjenja formule (I)ili na neku njegovu farmaceutski prihvatljivu so i solvat, gde R1 predstavlja F ili H, i na postupke za dobijanje tih jedinjenja, intermedijare koji se koriste pri tom dobijanju, na kompozicije koje ih sadrže i upotrebe tih jedinjenja. Jedinjenja u skladu sa ovim pronalaskom su korisna u brojnim bolestima, poremećajima i stanjima, a naročito u alergijskim i respiratornim bolestima, poremećajima i stanjima.
RSP-2009/0211A 2006-11-27 2007-11-14 Pyrazole analogs RS20090211A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86733706P 2006-11-27 2006-11-27
PCT/IB2007/003518 WO2008065493A1 (en) 2006-11-27 2007-11-14 Pyrazole analogs

Publications (1)

Publication Number Publication Date
RS20090211A true RS20090211A (en) 2010-10-31

Family

ID=39226772

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0211A RS20090211A (en) 2006-11-27 2007-11-14 Pyrazole analogs

Country Status (32)

Country Link
US (1) US7772269B2 (sr)
EP (1) EP2097407A1 (sr)
JP (1) JP4469924B2 (sr)
KR (1) KR20090074264A (sr)
CN (1) CN101541790A (sr)
AP (1) AP2009004849A0 (sr)
AR (1) AR063924A1 (sr)
AU (1) AU2007327004A1 (sr)
BR (1) BRPI0718672A2 (sr)
CA (1) CA2667566C (sr)
CL (1) CL2007003403A1 (sr)
CO (1) CO6180447A2 (sr)
CR (1) CR10745A (sr)
CU (1) CU23801B7 (sr)
DO (1) DOP2009000121A (sr)
EA (1) EA016588B1 (sr)
EC (1) ECSP099328A (sr)
GE (1) GEP20125386B (sr)
GT (1) GT200700104A (sr)
HN (1) HN2007000505A (sr)
IL (1) IL198412A0 (sr)
MA (1) MA30924B1 (sr)
MX (1) MX2009005526A (sr)
NO (1) NO20092413L (sr)
NZ (1) NZ576376A (sr)
PE (1) PE20081299A1 (sr)
RS (1) RS20090211A (sr)
TN (1) TN2009000205A1 (sr)
TW (1) TW200831495A (sr)
UA (1) UA92833C2 (sr)
UY (1) UY30743A1 (sr)
WO (1) WO2008065493A1 (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010004604A (es) 2007-11-26 2010-08-04 Pfizer Derivados de pirazol como inhibidores de 5-lo.
EP2151450A1 (de) * 2008-07-29 2010-02-10 Sandoz AG Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden
EP2563359A1 (en) * 2010-04-30 2013-03-06 Allergan, Inc. Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
US8759386B2 (en) * 2011-01-24 2014-06-24 Boehringer Ingelheim International Gmbh Pyrazole compounds as CRTH2 antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
US5753682A (en) 1993-06-14 1998-05-19 Pfizer Inc. Imidazole lipoxygenase inhibitors
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
JP3400392B2 (ja) * 1994-10-18 2003-04-28 ファイザー製薬株式会社 ５−リポキシゲナーゼ阻害剤及び新規医薬組成物
CA2232267C (en) 1995-09-18 2002-06-11 Pfizer Inc. Novel imidazole lipoxygenase inhibitors
US6194585B1 (en) * 1998-12-22 2001-02-27 Pfizer Inc. Process for preparing 5-lipoxygenase inhibitors
JP2001100682A (ja) * 1999-09-28 2001-04-13 Sanyo Electric Co Ltd サインシステム
JP2001100686A (ja) * 1999-09-28 2001-04-13 Hitachi Kokusai Electric Inc 表示データ取込方法及び比較検査装置

Also Published As

Publication number Publication date
UA92833C2 (en) 2010-12-10
AU2007327004A1 (en) 2008-06-05
KR20090074264A (ko) 2009-07-06
CA2667566A1 (en) 2008-06-05
JP4469924B2 (ja) 2010-06-02
EA016588B1 (ru) 2012-06-29
US7772269B2 (en) 2010-08-10
TW200831495A (en) 2008-08-01
ECSP099328A (es) 2009-06-30
TN2009000205A1 (fr) 2010-10-18
CR10745A (es) 2009-05-22
GT200700104A (es) 2011-04-13
CL2007003403A1 (es) 2008-07-04
CO6180447A2 (es) 2010-07-19
NO20092413L (no) 2009-07-20
HN2007000505A (es) 2010-06-09
CU23801B7 (es) 2012-03-15
CU20090083A7 (es) 2011-09-21
CN101541790A (zh) 2009-09-23
US20080125474A1 (en) 2008-05-29
EP2097407A1 (en) 2009-09-09
BRPI0718672A2 (pt) 2013-11-26
MA30924B1 (fr) 2009-11-02
UY30743A1 (es) 2008-07-03
GEP20125386B (en) 2012-01-25
PE20081299A1 (es) 2008-09-17
DOP2009000121A (es) 2009-06-15
EA200970422A1 (ru) 2009-12-30
MX2009005526A (es) 2009-06-05
CA2667566C (en) 2012-01-03
IL198412A0 (en) 2010-02-17
NZ576376A (en) 2011-02-25
AR063924A1 (es) 2009-02-25
WO2008065493A1 (en) 2008-06-05
JP2010511601A (ja) 2010-04-15
AP2009004849A0 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
MY143390A (en) Sulfonamide derivatives for the treatment of diseases.
NO20084005L (no) Aminderivater
RS20090137A (en) Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists
TW200833675A (en) Nicotinamide derivatives
WO2008005565A3 (en) Antiviral phosphinate compounds
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
ECSP11010754A (es) Derivados de triazol útiles para el tratamiento de enfermedades
TW200738741A (en) Antiviral compounds
TW200738742A (en) Antiviral compounds
MY177111A (en) Substituted amide derivatives and methods of use
TW200607494A (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
EA200601462A1 (ru) Соединения для лечения заболеваний
TW200505865A (en) Compounds useful for the treatment of diseases
IN2012DN02502A (sr)
WO2008074803A8 (en) 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists
TW200730498A (en) Compounds
MX2009005526A (es) Analogos de pirazol.
GB0116577D0 (en) Succinic acid derivatives
UA86615C2 (en) Formamide derivatives useful as adrenoceptor
MY144103A (en) Formamide derivatives useful as adrenoceptor
WO2009019719A3 (en) Process for the preparation of 3-aryloxy-3-arylpropanamines
UA96295C2 (en) Antiviral phosphinate compounds
CU23537B7 (es) Derivados de sulfonamida para el tratamiento de enfermedades
CU23532B7 (es) Derivados de sulfonamida para el tratamiento de enfermedades